The Vaccine Center's mission is to concentrate and enhance existing interests and expertise in vaccine research and the related areas of immunology and microbial pathogenesis. The Center will build on strengths in basic and translational research in providing a forum for open discussions and a focal point in the Philadelphia area for people with these same interests. A notable strength of the Center is the balance of scientists conducting basic and clinical research, an important requirement for the success of the hypothesis driven development of novel vaccines. The Vaccine Center's mission is to concentrate and enhance existing interests and expertise in vaccine research and the related areas of immunology and microbial pathogenesis. The Center will build on strengths in basic and translational research in providing a forum for open discussions and a focal point in the Philadelphia area for people with these same interests. A notable strength of the Center is the balance of scientists conducting basic and clinical research, an important requirement for the success of the hypothesis driven development of novel vaccines.
Jefferson Vaccine Center
Research
Bacterial Vaccines
- Dr. Kishore Alugupalli
- Dr. Scott Dessain
- Dr. Matthias Schnell
- Dr. Lance Simpson
Cancer Vaccines
- Dr. Vitali Alexeev
- Dr. Eugene Kennedy
- Dr. Hilary Koprowski
- Dr. Takemi Sato
- Dr. Scott Waldman
- Dr. Agnieszka Witkiewicz
Parasite Vaccines
Viral Vaccines
Hepatitis B Virus:
- Dr. Catherine Calkins
- Dr. Hilary Koprowski
HIV-1:
Influenza Virus:
Measles:
Poxviruses:
- Dr. Luis Sigal
Rabies Virus:
- Dr. Bernhard Dietzschold
- Dr. Hilary Koprowski
- Dr. James McGettigan
- Dr. Matthias Schnell
Viral Delivery Vectors:
- Dr. Rene Daniel
- Dr. James McGettigan
- Dr. Zahida Parveen
- Dr. Joseph Rabinowitz
- Dr. Matthias Schnell
Immune Responses to Vaccines
Antigen Presentation
B and T-Cell Functions
In the News
New Funding for JVC Members
Dr. McGettigan, was awarded a four-year $1.5 million R01 grant from the NIH to extend his exciting work on the development of a novel, safe, and effective rabies virus vaccine.
A Team of Researchers from Fox Chase, Jefferson and Penn State Receive NIAID Grant for Viral Control. Both Dr. Luis Sigal and Dr. Eisenlohr are members of the JVC. The team to receive a total of approximately $2 million each year for the next five years. For more information ...
Dr. David Abraham received a five year R01 grant to study the development of a recombinant vaccine against human onchocerciasis.
